IMAC (BACK) Competitors $1.36 +0.04 (+3.03%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends BACK vs. KDLY, ATPC, OTRK, OPGN, MGRX, BGLC, VSEE, DHAC, NIVF, and ACONShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Kindly MD (KDLY), Agape ATP (ATPC), Ontrak (OTRK), OpGen (OPGN), Mangoceuticals (MGRX), BioNexus Gene Lab (BGLC), Vsee Health (VSEE), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), and Aclarion (ACON). These companies are all part of the "healthcare" industry. IMAC vs. Kindly MD Agape ATP Ontrak OpGen Mangoceuticals BioNexus Gene Lab Vsee Health Digital Health Acquisition NewGenIvf Group Aclarion IMAC (NASDAQ:BACK) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, community ranking, dividends, profitability and institutional ownership. Do insiders and institutionals hold more shares of BACK or KDLY? 5.8% of IMAC shares are held by institutional investors. 4.6% of IMAC shares are held by insiders. Comparatively, 50.5% of Kindly MD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is BACK or KDLY more profitable? Company Net Margins Return on Equity Return on Assets IMACN/A N/A -359.33% Kindly MD N/A N/A N/A Does the MarketBeat Community prefer BACK or KDLY? IMAC and Kindly MD both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformIMACOutperform VotesNo VotesUnderperform Votes1100.00% Kindly MDN/AN/A Does the media refer more to BACK or KDLY? In the previous week, IMAC had 2 more articles in the media than Kindly MD. MarketBeat recorded 2 mentions for IMAC and 0 mentions for Kindly MD. IMAC's average media sentiment score of 0.54 beat Kindly MD's score of 0.00 indicating that IMAC is being referred to more favorably in the media. Company Overall Sentiment IMAC Positive Kindly MD Neutral Which has higher valuation and earnings, BACK or KDLY? Kindly MD has lower revenue, but higher earnings than IMAC. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIMAC$16.19M0.17-$9.42MN/AN/AKindly MDN/AN/AN/AN/AN/A SummaryIMAC beats Kindly MD on 4 of the 6 factors compared between the two stocks. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BACK vs. The Competition Export to ExcelMetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.72M$1.72B$5.39B$9.15BDividend YieldN/A0.30%5.37%4.00%P/E RatioN/A4.7888.2617.53Price / Sales0.1716.591,286.3180.33Price / CashN/A8.9536.6032.90Price / Book-2.051.464.954.68Net Income-$9.42M$36.27M$117.96M$224.57M7 Day Performance11.07%4.60%2.50%3.29%1 Month Performance11.98%9.58%3.42%5.32%1 Year Performance-32.92%-40.14%27.15%22.59% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BACKIMACN/A$1.36+3.0%N/A-34.7%$2.73M$16.19M0.00180Earnings ReportKDLYKindly MDN/A$1.44+0.8%N/AN/A$8.62M$2.88M0.00N/APositive NewsGap DownATPCAgape ATP0.2062 of 5 stars$1.97+56.3%N/A-85.9%$7.86M$1.35M-2.7040Gap UpHigh Trading VolumeOTRKOntrak2.693 of 5 stars$1.79+1.0%$45.00+2,416.4%-54.5%$7.54M$11.24M-0.17250OPGNOpGenN/A$0.80+1.3%N/A-31.8%$6.69M$2.67M0.00100Analyst ForecastNews CoverageMGRXMangoceuticalsN/A$2.60-2.6%N/A-96.4%$6.47M$755,000.00-0.453News CoveragePositive NewsBGLCBioNexus Gene Lab0.5317 of 5 stars$0.34+2.4%N/A-26.0%$6.02M$9.26M0.0030Positive NewsGap UpVSEEVsee HealthN/A$1.67+26.5%N/AN/A$6.01MN/A0.00N/APositive NewsHigh Trading VolumeDHACDigital Health AcquisitionN/A$1.32+0.8%N/A-88.1%$4.76MN/A0.002,021High Trading VolumeNIVFNewGenIvf Group1.538 of 5 stars$0.32-14.9%N/AN/A$3.20M$5.14M0.00N/ANews CoveragePositive NewsGap DownHigh Trading VolumeACONAclarion1.7369 of 5 stars$0.11-6.9%$1.30+1,090.5%-98.5%$1.35M$49,289.000.007 Related Companies and Tools Related Companies Kindly MD Competitors Agape ATP Competitors Ontrak Competitors OpGen Competitors Mangoceuticals Competitors BioNexus Gene Lab Competitors Vsee Health Competitors Digital Health Acquisition Competitors NewGenIvf Group Competitors Aclarion Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BACK) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.